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SIGNIFICANCE 
Eps15 (epidermal growth factor receptor pathway substrate 15)-homology domain containing 
proteins (EHDs) are molecular machines that use the energy of ATP binding and ATP hydrolysis 
to remodel shallow membranes into highly curved membrane tubules. This activity is required in 
many cellular membrane trafficking pathways. In this work, we have determined a high-resolution 
structure of an EHD machine in the active state. The structure indicates how EHDs assemble at 
the membrane surface into ring-like scaffolds that deform the underlying membrane. By 
comparing this active state with a previously determined autoinhibited conformation, we can 
deduce the mechanistic details how recruitment of EHDs to membranes is regulated. A comparison 
with other membrane-associated molecular machines reveals commonalities and differences in the 
activation mechanism. 
 
Keywords: dynamin superfamily, endocytic pathways, protein structure, membrane 
remodeling, autoinhibition 
 
ABSTRACT 
Eps15 (epidermal growth factor receptor pathway substrate 15)-homology domain containing 
proteins (EHDs) comprise a family of dynamin-related mechano-chemical ATPases involved in 
cellular membrane trafficking. Previous studies have revealed the structure of the EHD2 dimer, 
but the molecular mechanisms of membrane recruitment and assembly have remained obscure. 
Here, we determined the crystal structure of an amino-terminally truncated EHD4 dimer. 
Compared with the EHD2 structure, the helical domains are 50° rotated relative to the GTPase 
domain. Using electron paramagnetic spin resonance (EPR), we show that this rotation aligns the 
two membrane-binding regions in the helical domain toward the lipid bilayer, allowing membrane 
interaction. A loop rearrangement in GTPase domain creates a new interface for oligomer 
formation. Our results suggest that the EHD4 structure represents the active EHD conformation, 
whereas the EHD2 structure is autoinhibited, and reveal a complex series of domain 
rearrangements accompanying activation. A comparison with other peripheral membrane proteins 
elucidates common and specific features of this activation mechanism. 
 
INTRODUCTION 
Eps15 (epidermal growth factor receptor pathway substrate 15)-homology domain 
containing proteins (EHDs) comprise a highly conserved eukaryotic family of dynamin-related 
ATPases, which regulate diverse membrane trafficking pathways (1). The single Caenorhabditis 
elegans homolog receptor-mediated endocytosis 1 (Rme-1) localizes to the endocytic recycling 
compartment and mediates the exit of cargo proteins to the cell surface (2, 3). Similar functions 
were subsequently shown for mammalian EHD1 and EHD3, which in addition control early 
endosome to Golgi transport (4–6). EHD4/Pincher facilitates the macroendocytic uptake of 
tropomyosin receptor kinase (Trk) receptors (7, 8). In contrast, EHD2 localizes to caveolae and, 
together with the Bin Amphiphysin Rvs (BAR)-domain containing binding partner PACSIN2 (9), 
stabilizes caveolae at the cell surface (10–12). Despite possessing a dynamin-related GTPase 
domain, EHDs bind to adenine rather than guanine nucleotides (13, 14). Similar to other dynamin 
superfamily members, EHD2 tubulates negatively charged liposomes and forms ring-like 
oligomers around the tubulated membranes (14, 15). Furthermore, the slow ATPase rate of EHD2 
is stimulated by the assembly on membrane surfaces. 
The crystal structure of the EHD2 dimer in the presence of the nonhydrolyzable ATP 
analog adenylyl imidodiphosphate (AMPPNP) revealed a dynamin-related extended GTPase 
domain that mediates stable dimerization via an EHD family-specific dimerization interface (14). 
The helical domain is composed of amino acid sequences lining the GTPase domain at its N and 
C terminus. We previously demonstrated by mutagenesis and electron paramagnetic spin 
resonance (EPR) that helix α9 at the tip of the helical domain participates in membrane binding 
(14, 16). The Eps15-homology (EH) domains at the C terminus interact with linear peptide 
sequences containing Asn-Pro-Phe (NPF) motifs (17, 18). In the EHD2 dimer, they bind to an 
internal Gly-Pro-Phe (GPF) motif in the linker between the helical domain and the EH domain. 
This interaction locks the EH domain to the opposing GTPase domain, from where it delivers its 
C-terminal tail into the active site (14). In this way, the EH domains were suggested to block a 
highly conserved second assembly site in the GTPase domain, which extends across the nucleotide 
binding site. GTPase domain assembly via this “G interface” is a conserved feature in the dynamin 
superfamily and is often accompanied by activation of the GTPase activity (19). 
Our recent X-ray and EPR structural analysis demonstrated that an N-terminal stretch of 8 
aa folds back into a highly conserved hydrophobic pocket of the GTPase domain in the EHD2 
dimer (16). Upon its recruitment to membranes, the N-terminal residues are released and may 
insert into the lipid bilayer. This switch mechanism appears to negatively regulate membrane 
interaction of EHDs, because an EHD2 variant without the N-terminal residues showed enhanced 
membrane binding when overexpressed in mammalian cells. We suggested that the switch may 
also influence the partly disordered “KPF loop” (containing a Lys-Pro-Phe amino acid stretch) at 
the distal side of the GTPase domain that is required for caveolar targeting of EHD2 (10). 
In this study, we elucidated the structural basis for the switch mechanism by determining 
the crystal structure of an N-terminally truncated EHD4 dimer in the oligomerized state. We reveal 
a complex series of domain rearrangements during activation and uncover common and specific 
features of this activation mechanism compared with other membrane-activated systems. 
 
RESULTS 
 
Crystal Structure of the EHD4 Dimer. 
To obtain mechanistic insights into the activation mechanism of EHD proteins, we 
expressed and purified an N-terminally truncated EHD4 variant (amino acids 22–541, EHD4ΔN; 
Fig. 1A). We reasoned that this variant may mimic the situation when EHDs are activated by 
membrane recruitment and release their N terminus from the GTPase domain (16). An EHD4 full-
length construct was insoluble when expressed in Escherichia coli. 
Similar to EHD2, EHD4ΔN bound to the nonhydrolyzable ATP analog adenosine 5′-(γ-
thio)-triphosphate (ATPγS) with a micromolar affinity in isothermal titration calorimetry (ITC) 
experiments (Fig. S1A). Furthermore, EHD4ΔN cosedimented with liposomes derived from 
bovine brain (Folch) lipids (Fig. S1B). Membrane binding resulted in liposome tubulation, and 
regular EHD4ΔN oligomers were formed at the surface of the lipid tubules (Fig. 1B and Fig. S1C). 
In addition, the slow ATPase activity of EHD4ΔN was 200-fold stimulated by the addition of 
Folch liposomes (Fig. 1C). The stimulated ATPase rate of EHD4ΔN is sevenfold higher compared 
with EHD2 under identical conditions (14). When C-terminally GFP-tagged EHD4 was 
overexpressed in HeLa cells, it localized to endosomal structures that partially overlapped with 
early endosomal antigen1 (EEA1) (Fig. 1D, Left and Fig. S2, see also ref. 20). The N-terminally 
truncated EHD4 variant showed increased membrane association (Fig. 1D, Right, quantified in 
Fig. S1 D and E). Many membranous structures appeared tubulated in these cells, pointing to an 
increased membrane remodelling activity of EHD4ΔN. Taken together, these results indicate that 
EHD2 and EHD4 use related mechanisms of membrane recruitment and oligomerization. In 
particular, the N-terminal residues appear to negatively control membrane recruitment in both 
proteins. 
For EHD4ΔN, crystals of the same space group were obtained in the presence of ATPγS 
and ADP and diffracted to a maximal resolution of 2.8 Å and 3.3 Å, respectively (Table S1). The 
structures were solved by molecular replacement and refined to Rwork/Rfree of 22.7%/24.3% and 
20.8%/25.0%, respectively. Besides minor changes in the nucleotide binding site, both structures 
were essentially identical, with a rms deviation (rmsd) of 0.30 Å for all built Cα atoms (Fig. S3A). 
If not otherwise mentioned, we refer in the following to the higher resolution ATPγS-bound 
structure. 
The overall architecture of EHD4ΔN is similar to that of AMPPNP-bound EHD2 (Fig. 1E). 
For example, the GTPase domains of EHD4 and EHD2 show a highly related fold (rmsd of 0.92 
Å for 194 aligned Cα atoms; Fig. S3B). They form a dimer via an interface involving helix α6, 
including Arg234, Tyr236, and Trp241 (Fig. 1E and Fig. S3C). The interface is highly conserved 
in EHD proteins (Fig. S4) (14), but not in other dynamin-related proteins. 
Electron density for ATPγS and ADP was clearly discernible in the nucleotide-binding 
pocket (Fig. S5 A and B). Switch I in the ATPγS-bound EHD4ΔN structure adopts a different 
conformation compared with EHD2 (Fig. S5C). For example, the completely invariant Thr97 
(Thr94 in EHD2), which coordinates the Mg2+ ion in EHD2 (14) and, in analogy to dynamin (21), 
may position a catalytic water molecule for nucleotide hydrolysis, points away from the nucleotide 
in the EHD4ΔN structure. The reorientation of switch I may be caused by a newly formed contact 
of Arg138 from the rearranged KPF loop (see below) with the main chain of Thr96 in switch I. In 
the ADP-bound structure, switch I is disordered. These observations suggest an ATP-dependent 
conformational cross-talk between the KPF loop and the nucleotide-binding site in EHD proteins. 
The EH domains were not resolved in the electron densities, despite being present in the 
crystallized construct. SDS/PAGE analysis of dissolved crystals showed no hints for proteolytic 
degradation. This observation indicates that the EH domains are disordered in the crystals and do 
not bind to their autoinhibitory site on top of the GTPase domains. 
 
A Large-Scale Rotation of the Helical Domain Promotes Activation. 
The helical domain of EHD4ΔN has an almost identical architecture as its counterpart in 
EHD2 (rmsd of 0.67 Å for 142 Cα atoms). However, compared with EHD2, it is rotated by ∼50° 
relative to the GTPase domain around a hinge featuring the invariant Pro289 (Fig. 2A and Movie 
S1). This rotation pushes the N-terminal residues of the linker to the EH domain 12 Å away (Fig. 
S6 A–C). In the EHD2 structure, the linker makes prominent contacts to the GTPase domain and 
binds via a GPF motif to the EH domain of the opposing monomer. The rotation may thus displace 
the linker, therefore releasing the EH domain from its autoinhibitory site. It also reorients the 
membrane binding site in α9 including Thr320, Val321, Phe322, and Lys328, which, in EHD2, 
were shown to directly interact with the membrane (16) (Fig. 2 A–C). 
To understand the consequences for membrane binding, we used the previously established 
EPR assay for EHD2 as a model for the EHD family. In these experiments, a single paramagnetic 
spin probe is attached to a single cysteine introduced at a specific site in an otherwise cysteine-
free EHD2 variant. The accessibility of the spin label toward paramagnetic spin colliders, such as 
oxygen and nickel ethylenediamine diacetic acid (NiEDDA), can provide information on the 
membrane immersion of the spin label (22). Using this assay, we now demonstrate that not only 
the N-terminal part of α9 at the tip of the stalk, but also Gln330, Leu331, and Leu333 at the C-
terminal end of α9, contribute to membrane binding (Fig. 2 B and C). Furthermore, we show that 
Cys356 in the adjacent helix α11 directly interacts with the membrane. In contrast, Val337 and 
A340 in α10, which is bent away from α9 and α11, did not penetrate into the membrane (Fig. 2 B 
and C). These results suggest that the membrane interaction site in EHD proteins extends along 
the parallel helices α9 and α11, which, together with the entire helical domain, move en bloc during 
activation. In the autoinhibited EHD2 structure, the membrane binding sites from two opposing 
monomers point away from each other (Fig. 2D). In contrast, in the EHD4ΔN structure, the lipid 
binding regions reorient in a parallel fashion toward the membrane surface for binding. These 
results suggest that the EHD4ΔN structure represents a membrane-binding competent, active 
conformation. 
 
A Switch in the GTPase Domains Allows Oligomerization. 
In the EHD2 structure, the helical domains form several salt bridges to the GTPase domain 
of the same monomer (Fig. 3A, black box). The corresponding salt bridges are broken in the 
EHD4ΔN structure (Fig. 3B, black box). Furthermore, we previously demonstrated that the N-
terminal 8 aa in the autoinhibited EHD2 dimer fold back into a hydrophobic pocket of the GTPase 
domain (Fig. 3A) (16). In EHD4ΔN, the hydrophobic pocket in the GTPase domain is occupied 
by the adjacent KPF loop, which undergoes a large-scale reorientation (Fig. 3B, blue box, Movie 
S1). Conserved residues in this loop, such as Phe125, Leu128 and Phe131, anchor the helix into 
this pocket, whereas in the auto-inhibited EHD2 structure, the highly conserved Trp4 and Met5 of 
the N terminus (Fig. S4) occupy the equivalent space. These observations suggest that during the 
activation process, the KPF loop switches into the hydrophobic binding pocket of the GTPase 
domain. 
When analyzing the crystal packing, we noticed that EHD4ΔN dimers assembled in a linear 
fashion in the crystals (Fig. 4A and Fig. S7 A and B). In these oligomers, the membrane binding 
sites of the helical domain were oriented in the same direction, suggesting a physiologically 
plausible assembly. The oligomer had the same width (90 Å) as single EHD4 filaments sometimes 
observed on tubulated liposomes (Fig. S1C). Furthermore, the GTPase domains of adjacent 
EHD4ΔN dimers directly opposed each other via the highly conserved G interface, although they 
were separated by a small gap (Fig. 4A, Right). We previously proposed a similar oligomerization 
model for EHD2, but without the rotation of the helical domains (14). 
When analyzing the oligomerization determinants in these linear EHD4ΔN assemblies, we 
found that the rearranged KPF loop interacted via a highly conserved interface with the helical 
domain of the adjacent dimer (Fig. 4B and Fig. S7 B and C). To probe the involvement of this new 
interface for oligomerization, we aimed to disrupt it by introducing the F125A and K302A/R305A 
mutations in EHD4ΔN (Figs. 3 and.4B). Both mutants still bound to liposomes (Fig. S1B). 
Whereas the F125A completely lost its ability to remodel membranes, the K302A/R305A mutant 
showed reduced remodeling of membranes, as indicated by the formation of less and irregular 
membrane tubules (Fig. 4C). Both mutants showed slightly increased basal ATPase rates, which, 
however, were not or only to a minor extent stimulated by the addition of liposomes (Fig. 4D). 
When these N-terminal deletion variants were overexpressed in HeLa cells, they showed a severe 
loss of membrane recruitment (Fig. 4E and Fig. S1 D and E), and similar results were previously 
obtained for the F122A mutant of EHD2 (corresponding to F125A in EHD4; Fig. S4) (10). We 
also attempted to stabilize the oligomerization interface in full-length EHD4 by introducing the 
A116L and N133D mutations to enhance hydrophobic interactions and create an additional salt 
bridge to Lys302, respectively. When expressed in HeLa cells, the single mutants showed similar 
membrane recruitment compared with EHD4 (Fig. S1 D and E). Strikingly, the double mutant 
showed greatly enhanced membrane recruitment, consistent with an increased oligomerization 
activity. Taken together, these data suggest that upon membrane recruitment and release of the N 
terminus, the KPF loop switches into the hydrophobic pocket of the GTPase domains and promotes 
oligomerization. A contact of the rearranged KPF loop with the open helical domain of the adjacent 
EHD dimer contributes to the regular assembly of EHDs on membranes. 
 
DISCUSSION 
Membrane-associated assembly processes of peripheral membrane proteins are 
challenging to study at the structural level, and only in very few cases, high-resolution structures 
of such proteins in the autoinhibited and the activated, oligomerized form have been described. By 
removing the autoinhibitory N-terminal sequence, we obtained a membrane-binding and 
oligomerization-competent conformation of EHD4, which we consider as the active conformation 
[see also related manuscript by Hoernke et al. (23)]. In contrast, the membrane binding sites in the 
previous EHD2 structure were oriented away from the membrane. We therefore refer to the EHD2 
structure as an autoinhibited conformation. A comparison between the active and autoinhibited 
form reveals a complex domain rearrangement in EHD proteins accompanying activation, 
resulting in an activation model for EHDs (Fig. 5). In the autoinhibited cytosolic form, the N 
terminus is locked in the GTPase domain and the EH domains block the assembly. Upon 
membrane recruitment, a series of conformational changes is triggered: (i) The N terminus of 
EHDs is released from the GTPase domain and may switch into the membrane (Fig. S7B for 
further discussion). This switch appears to activate EHDs because the EHD4ΔN construct is in the 
active conformation even in the absence of membranes and in both the ATP- and ADP-bound 
states (Fig. S3A). (ii) The helical domains rotate around the conserved Pro289. A similar rotation 
mechanism was observed for dynamin and suggested to act as a power stroke (19). In contrast, the 
domain rotation of the helical domains in EHDs appears to regulate membrane binding by 
adjusting the position of the membrane-binding site in α9 and α11. (iii) Concomitant with the 
rotation of the helical domain, the linker to the EH domain is dislodged from the GTPase domain. 
Consequently, the EH domains are displaced from their autoinhibitory site on the GTPase domain, 
as observed in the EHD4ΔN structure. In cells, this release may be further promoted by interactions 
of the EH domain with NPF motif-containing binding partners, such as syndapins/PACSINs (9, 
12) and MICAL-L1 (24). (iv) Our structural analysis indicates that the KPF loop moves into the 
hydrophobic pocket of the GTPase domain. This loop creates a new assembly interface with the 
helical domain of the adjacent EHD dimer, therefore stabilizing the active conformation and 
promoting oligomerization of EHDs at the membrane. (v) In addition, the nucleotide-loading state 
of EHDs may affect the activation by nucleotide-dependent stabilization of the N-terminal loop or 
the KPF loop in the GTPase domain. Supporting this hypothesis, the KPF loop and switch I interact 
in an ATP-dependent manner. Furthermore, the removal of the EH domain tail from the active site 
may allow the ATP-dependent oligomerization of EHDs in ring-like structures via the conserved 
G-interface, which could explain the strict ATP dependency of assembly (Movie S2) (16). Such 
assembly would facilitate (vi) a direct coupling of EHD oligomerization with the creation of 
membrane curvature. 
Whereas the overall architecture of EHDs is related to dynamin, the oligomerization modes 
of these proteins differ fundamentally: Oligomerization of dynamin/MxA/DNM1L in helical 
filaments is mediated by three assembly interfaces in the helical stalk (19). The GTPase domains 
contribute to assembly by mediating GTPase-dependent contacts between adjacent filaments. In 
this way, nucleotide binding and hydrolysis can induce the rearrangement of adjacent filaments 
assembled via the stalk, leading to constriction of the underlying membrane. In contrast, EHDs 
use a unique interface in the GTPase domain for dimerization and use the ATP-dependent G 
interface for further oligomerization. Contacts between the GTPase domain and the helical domain 
of the next dimer contribute to oligomer formation. The architecture of the EHD oligomers 
excludes a nucleotide-driven sliding mechanism because nucleotide-dependent contacts are 
formed within and not between adjacent filaments. However, the assembly mode is well suited for 
the stabilization of membrane curvature by oligomerizing into ring-like tubular oligomers. 
Despite the involvement of different domains, there are striking parallels in the activation 
mechanisms of EHDs and dynamin (Fig. S8). In the autoinhibited dynamin tetramer, an 
intramolecular contact of the pleckstrin homology (PH) domain with the oligomerization surface 
of the stalk prevents the assembly in the cytosol (25), whereas an autoinhibitory contact of the C-
terminal EH domain with the GTPase domains takes over this function in EHDs. Such 
intramolecular inhibitory contacts are also observed in other peripheral or integral membrane 
proteins, such as BAR-domain containing proteins (26, 27), SNAREs (28), ESCRT-III (29), or the 
WASP protein (30) (Fig. S8 B–E). Binding of specific elements to membranes or interaction 
partners shifts the equilibrium toward the active state. The formation of new interactions in the 
membrane-bound oligomer is accompanied by the loss of intramolecular interactions in the 
autoinhibited dimer. Such mechanism may allow reversibility of membrane recruitment and 
oligomerization. 
Taken together, our study elucidates a complex activation mechanism of EHD family 
proteins, revealing common and specific features how peripheral membrane proteins scaffold 
cellular membranes. 
 
MATERIALS AND METHODS 
Protein expression and purification were carried out as described before (14). A detailed 
description of the purification, crystallization, structure solution, refinement, biochemical 
experiments, electron microscopy, cell biology and microscopy analysis can be found in SI 
Materials and Methods. 
 
Supplemental Information - MATERIALS AND METHODS 
 
Protein Expression and Purification. 
Mouse EHD4 (residues 22–541, EHD4ΔN) and the indicated mutants were expressed from a 
modified pET28 vector as N-terminal His6-tag fusions followed by a PreScission protease 
cleavage site, according to ref. 14. Expression plasmids were transformed in Escherichia coli host 
strain BL21(DE3)-Rosetta2 (Novagen). Cells were grown at 37 °C in TB medium, and protein 
expression was induced at an optical density of 0.5 by the addition of 40 µM isopropyl-β-d-
thiogalactopyranoside (IPTG), followed by overnight incubation at 18 °C. Upon centrifugation, 
cells were resuspended in 50 mM Hepes/NaOH (pH 7.5), 500 mM NaCl, 25 mM imidazole, 2 mM 
MgCl2, 2.5 mM β-mercaptoethanol (β-ME) including 1 mM Pefabloc protease inhibitor (Carl 
Roth) and 1 µM DNase I (Roche) and lysed in a microfluidizer (Microfluidics). Following 
centrifugation (30,000 × g, 1 h, 4 °C), cleared lysates were applied to a NiNTA column (GE 
Healthcare). The column was then extensively washed with 50 mM Hepes/NaOH (pH 7.5), 700 
mM NaCl, 10 mM CaCl2, 1 mM ATP, 10 mM MgCl2, 10 mM KCl, and afterward with 50 mM 
Hepes/NaOH (pH 7.5), 500 mM NaCl, 25 mM imidazole, 2 mM MgCl2, 2.5 mM β-ME. The 
protein was eluted with 50 mM Hepes/NaOH (pH 7.5), 500 mM NaCl, 2 mM MgCl2, 2.5 mM β-
ME, and 300 mM imidazole. One hundred fifty micrograms of PreScission protease per 5 mg of 
the EHD constructs was added and the protein was dialyzed overnight against 50 mM 
Hepes/NaOH (pH 7.5), 500 mM NaCl, 1 mM MgCl2 and 2.5 mM β-ME. Following reapplication 
of the protein to a NiNTA column to remove the His tag and uncleaved protein, EHD4ΔN was 
concentrated by using a 50-kDa molecular mass cutoff concentrators (Amicon) and applied to a 
Superdex200 gel filtration column (GE Healthcare) equilibrated with 50 mM Hepes/NaOH (pH 
7.5), 500 mM NaCl, 1 mM MgCl2, and 2.5 mM β-ME. Fractions containing the EHD constructs 
were pooled, concentrated, and flash-frozen in liquid nitrogen. The purified protein was 
nucleotide-free, as judged by HPLC analysis. 
 
Crystallization and Structure Determination. 
Initial crystallization trials by the sitting-drop vapor-diffusion method were performed at 20 °C, 
using a Gryphon LCP pipetting robot (Art Robbins Instrument) and Rock Imager storage system 
(Formulatrix). Subsequently, conditions were refined in the 24-well format by using hanging 
drops. One microliter of mouse EHD4ΔN at a concentration of 10 mg/mL was mixed with 2 µL 
of the reservoir solution containing 26% (wt/vol) sodium polyacrylate 5100, 200 mM MgCl2, 100 
mM Hepes/NaOH (pH 7.5) in the presence of 2 mM ATPγS, or 900 mM sodium malonate (pH 7) 
in the presence of 2 mM ADP. In both cases, rod-shaped crystals appeared after 1 d at 20 °C. 
Crystals were cryoprotected by transfer into a solution containing 50% (vol/vol) of the buffer and 
reservoir components and 20% (vol/vol) glycerol and flash-cooled in liquid nitrogen. Data were 
recorded at beamline BL-14.1 at BESSY-II (Berlin) at a temperature of 100 K and a wavelength 
of 0.9184 Å. Data from single crystals were processed and scaled by using the program package 
XDS (31) and XDSAPP (32). The structure was solved by molecular replacement with Phaser (33) 
using the individual G domain and helical domain of EHD2 (PDB ID code 4CID) as search models. 
The model was built by using Coot (34) and iteratively refined by using Phenix (35) with three 
translation, libration, and screw-rotation (TLS) parameters per molecule. For the ATPγS-bound 
structure, 96% of all residues are in the most favored regions of the Ramachandran plot and 0.5% 
in the disallowed regions; for the ADP-bound structure, 93.5% of all residues are in the most 
favored regions of the Ramachandran plot and 1.1% in the disallowed regions. Figures were 
prepared with the PyMOL Molecular Graphics System Version 1.8, Schrödinger, LLC and 
Chimera (36). The molecular morph was created in Chimera. Domain superpositions were 
performed with Coot. The surface conservation plot was calculated and visualized by using 
Chimera. 
 
Liposome Cosedimentation Assays. 
Liposomes were prepared as described (www.endocytosis.org). Folch liposomes (total bovine 
brain lipids fraction I from Sigma) in 20 mM Hepes/NaOH (pH 7.5), 300 mM NaCl, and 1 mM 
DTT were sonicated in a water bath for 30 s. Liposomes (0.2 mg/mL) were incubated at room 
temperature with 10 µM of the indicated EHD4 construct for 10 min in 40 µL of reaction volume, 
followed by a 213,000 × g spin for 10 min at 20 °C. The final reaction buffer contained 25 mM 
Hepes/NaOH (pH 7.5), 300 mM NaCl, and 0.5 mM MgCl2. 
 
 
ATP Hydrolysis Assay. 
ATPase activities of 10 µM of the indicated EHD4 constructs were determined at 30 °C in 25 mM 
Hepes/NaOH (pH 7.5), 300 mM NaCl, and 0.5 mM MgCl2 in the absence and presence of 1 
mg/mL nonextruded Folch liposomes, using 100 µM ATP as the substrate. Reactions were 
initiated by addition of protein to the reaction. At different time points, reaction aliquots were 
fivefold diluted in reaction buffer and quickly transferred to liquid nitrogen. Nucleotides in the 
samples were separated via a reversed-phase Hypersil ODS-2 C18 column (250 × 4 mm) with 100 
mM potassium phosphate buffer pH 6.5, 10 mM tetrabutylammonium bromide, 7.5% (vol/vol) 
acetonitrile as running buffer. Denatured proteins were adsorbed on a C18 guard column. 
Nucleotides were detected by absorption at 254 nm and quantified by integration of the 
corresponding peaks. Rates were derived from a linear fit to the initial reaction (<40% ATP 
hydrolyzed). 
 
Electron Microscopy. 
For membrane tubulation assays, 10 µM EHD4ΔN in 25 mM Hepes/NaOH (pH 7.5), 300 mM 
NaCl, 1 mM MgCl2, and 1 mM ATP were incubated at room temperature for 20 min with 1 mg/mL 
liposomes. Samples were spotted on carbon-coated copper grids (Plano) and negatively stained 
with 2% uranyl acetate. Electron grids were imaged with a transmission electron microscope at 80 
kV (EM 910; Zeiss) and acquisition was done with a CCD camera (Quemesa; Olympus Viewing 
System). 
 
EPR Power Saturation Experiments. 
These experiments were carried out as described in ref. 16 at a concentration of ∼2 g/L. 
Accessibilities to O2 (from air, ΠOx) and 10 mM NiEDDA (ΠNiEDDA) were obtained from 
power saturation experiments by using a Bruker EMX X-Band ESR spectrometer fitted with 
ER4123D dielectric resonator. The depth parameter Φ was calculated from Φ = 
ln[ΠOx/ΠNiEDDA] (16) and the membrane insertion depth was obtained as described in ref. 16. 
 
Cell Biology and Microscopy. 
HeLa cells (ATCC-CRM-CCL-2) were grown in DMEM (Gibco) supplemented with 10% 
(vol/vol) FBS (Invitrogen). For confocal imaging, 80,000 cells were seeded on 1.5 high tolerance 
glass coverslips 25 mm (Warner Instruments) 24 h before transfection. EHD4-mCherry constructs 
were transiently transfected by using Lipofectamine 2000 (Invitrogen) according to manufacturer's 
instructions 16–24 h before the experiment. The microscope stage and objective lenses were 
maintained at 37 °C within an environmental chamber supplemented with 5% (vol/vol) CO2. 
Images were acquired with a Zeiss Cell Observer Spinning Disk Confocal controlled by ZEN 
interface with an Axio Observer.Z1 inverted microscope, equipped with a CSU-X1A 5000 
Spinning Disk Unit and a EMCCD camera iXon Ultra from ANDOR. Cells were imaged in 
DMEM lacking Phenol Red (Gibco) supplemented with 10% (vol/vol) FBS. For epifluorescence 
analysis, cells were fixed in 3% (vol/vol) paraformaldehyde in PBS for 20 min at room 
temperature, then washed and blocked in 5% (vol/vol) goat serum with 0.05% saponin in PBS 
before staining with mouse anti-EEA1 (clone 14, 610456, BD Biosciences) in 1% goat serum, 
0.05% saponin in PBS using standard protocols. Images were acquired by using a Zeiss Axio 
Imager Z1 system with Zen software. The representative microscopic images were cropped by 
using ImageJ (NIH). 
 
Image Analysis and Statistics. 
The SDs of the image histogram from maximum intensity projections of confocal stacks were used 
to measure the textures of the different mutants. A ROI of fixed size was applied within an area 
with representative texture and the SDs of the gray values were measured by using ImageJ. 
Statistical analysis was performed byusing Prism5 (GraphPad Software). 
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FIGURES 
 
 
Figure 1. Structure of the activated EHD4 dimer. (A) Domain architecture of EHD proteins. Numbers 
refer to the amino acid sequence of mouse EHD4. (B) EM micrographs of negatively stained 
EHD4ΔN in the presence of liposomes. As a control, liposomes were stained without the addition of 
EHD4ΔN. (Scale bars: B, 500 nm; D, 10 μm.) (C) ATPase assays of EHD4ΔN in the absence and presence 
of Folch liposomes were carried out at 30 °C. Error bars represent the range of two independent 
measurements. (D) EHD4 and EHD4ΔN were expressed in HeLa cells with a C-terminal mCherry tag. 
(E) Structure of the ATPγS-bound EHD4ΔN. In the left molecule, domains are colored according to the 
domain architecture, the conserved hinge around Pro289 is indicated in green. The right molecule is 
shown in gray. Note that the EH domains were not resolved in the electron density. 
 
Figure 2. A rotation of the helical domains allows membrane binding. (A) Superposition of the GTPase 
domains of ATPγS-bound EHD4ΔN and AMPNP-bound EHD2 (PDB ID code 4CID, only the helical 
of EHD2 is shown). Pro289 acts as the hinge for a 50° rotation of the helical domain. (B) Magnification 
of the boxed area in A showing details of the membrane binding interface of EHD2. Membrane 
inserting (green)/noninserting (yellow) residues are highlighted. (C) The logarithmic ratio Φ of the 
accessibilities of spin labels to the paramagnetic colliders O2 and NiEDDA was calculated for EHD2 
labeled at the indicated positions in the presence of Folch-SUVs (open bars referring to the left y axis). 
Results from residues 277, 320–324, and 328 (*) are from ref. 16. Positive Φ values indicate membrane 
insertion based on prior calibration with spin-labeled lipids. This calibration was used to convert Φ 
values into membrane insertion depth of each residue (filled bars to the right y axis). (D) Electrostatic 
potentials (±10 kcal/mol × e, where e is the charge of an electron) were plotted on the surfaces of the 
EHD2 (Left) and EHD4ΔN (Right) dimers, with the GTPase domains of both dimers in the same 
orientation. The distances between Phe322-Phe322 in EHD2 (56 Å), Phe325-Phe325 in EHD4 (130 
Å), Pro350-Pro350 in EHD2 (28 Å), and Ala353-Ala353 in EHD4 (80 Å) are indicated. The membrane 
binding surface of EHD2 is more positively charged compared with EHD4, possibly reflecting 
different lipid binding specificities (Fig. S4). 
 
Figure 3. The KPF loop undergoes a large-scale reorientation upon activation. (A) Structure of EHD2 
(PDB ID code 4CID). The black box highlights the contacts of the helical domain with the GTPase 
domain and the N terminus in the autoinhibited state. The blue box shows the localization of the N 
terminus in a hydrophobic groove of the GTPase domain. (B) Structure of EHD4ΔN, with the same 
orientation of the GTPase domain as in A. The black box features the broken contacts between the 
helical domain and the GTPase domain in the active state. The blue box shows that the KPF loop 
occupies the hydrophobic groove in the GTPase domain, with Phe125, Leu128, and Phe131 
(corresponding to Phe122, Leu125, and Phe128 in EHD2) acting as anchor points. Because of three 
extra amino acids in the N-terminal region of EHD4, the numbering of residues on EHD4 (residues 
13–541) corresponds to the EHD2 residue number plus three (Fig. S4). 
 
  
Figure 4. Oligomerization via a new interface between the KPF loop and the helical domain. (A) Two 
views on the EHD4ΔN oligomers in the crystals represented by two dimers. One dimer is colored as 
in Fig. 1E, whereas the other is colored in light blue. Note the gap between the G interfaces of 
assembling dimers (Right). (B) Insetshows details of the oligomerization surface involving the KPF 
loop and the helical domain of the opposing dimer. (C) Liposome tubulation of EHD4ΔN, 
EHD4ΔNF125A and EHD4ΔN K302A/R305A, as in Fig. 1B. (D) Basic and stimulated ATP hydrolysis 
reactions of EHD4ΔN F125A and EHD4ΔN K302A/R305A were carried out as in Fig. 1C. (E) 
Expression of mCherry-tagged EHD4ΔN F125A and EHD4ΔN K302A/R305A in HeLa cells, as in Fig. 
1D. (Scale bars: C, 500 nm; E, 10 μm.). 
 
  
 
Figure 5. Activation model of EHDs. For details see Discussion; the numbers refer to release of the N 
terminus into the membrane (1), rotation of the helical domain (2), release of the EH domains from the 
autoinhibitory site (3), insertion of the KPF-loop into the hydrophobic pocket of the GTPase domain 
(4), membrane binding and oligomerization (5), and membrane tubulation (6). 
 
  
SUPPLEMENTAL FIGURES 
 
 
Figure S1. Functional characterization of EHD4ΔN. (A) In ITC experiments, a 2 mM ATPγS solution 
was titrated into a 70 µM EHD4ΔN solution. The resulting heat changes were integrated and fitted to 
a quadratic binding model. A KD of 77 µM, with a binding number n of 0.67 was obtained. Note that 
this experiment was carried out at 500 mM NaCl, which was required to prevent protein precipitation. 
The high salt concentration may negatively influence the binding affinity. (B) Folch liposome 
cosedimentation assays of EHD4ΔN and the indicated mutants. P, Pellet fraction; SN, supernatant. (C) 
Liposome tubulation experiments as in Fig. 1B. Some tubulated liposomes (arrowhead) contained a 
regular EHD4 coat with striations of 9 nm width (black arrows), which corresponds to the width of our 
EHD4 oligomeric model (Fig. 4A). (D) Representative maximum intensity projections of live HeLa 
cells expressing mCherry-tagged protein as indicated. White circles illustrate typical placings of the 
region of interest (ROI) within the cells. (E) SD of gray values derived from one ROI per cell from at 
least 20 cells for each indicated construct. Error bars show SEM. Two-tailed t tests was performed on 
EHD4ΔN to each set of data to determine significance *P ≤ 0.05, **P ≤ 0.005, ***P ≤ 0.0001. (Scale 
bars: 10 μm.) 
 
  
 
Figure S2. Deletion of the N terminus increases EHD4 localization at early endosomes. Endogenous 
staining of EEA1 in HeLa cells expressing mCherry-tagged protein as indicated. Arrowheads 
exemplify colocalization of mCherry-tagged protein and EEA1. (Scale bars: 10 μm.) 
  
 
Figure S3. Structural comparisons within the EHD family. (A) A superposition of the EHD4ΔN 
ATPγS and ADP-bound structures. Only minor changes in the GTPase domains were apparent (Right). 
Note that in the ADP-bound EHD4 structure, switch I is disordered. (B) A superposition of EHD2 and 
EHD4 GTPase domain dimers indicates an almost identical architecture. (C) Interaction details in the 
GTPase domain dimerization interface of EHD4ΔN. 
 
  
 
 
Figure S4. Sequence alignment of the crystallized mmEHD4 and human EHDs. Amino acid sequences 
of Mus musculus (mm) EHD4 (Q9EQP2), Homo sapiens (hs) EHD1 (Q9H4M9), hsEHD2 (Q9NZN4), 
hsEHD3 (Q9NZN3), and hsEHD4 (Q9H223) were aligned by using CLUSTAL W and manually 
adjusted. Residues with a conservation greater than 70% are color-coded (D, E in red; R, K, H in blue 
N, Q, S, T in gray; A, L, I, V, F, Y, W, M, C in green and P, G in brown). α-Helices are shown as 
cylinders and β-strands as arrows. The secondary structure of the EH domain is from PDB ID code 
4CID. The domains are colored as in Fig. 1E. Mutated residues in this study are indicated with an 
asterisk (*), residues interacting with the membrane are indicated with a clover (♣), and residues 
interacting with ATPγS are indicated with a heart (♥). 
 
  
Figure S5. Structural details of the GTPase domain. (A and B) Detailed view into the catalytic site of 
the ATPγS and ADP-bound structures, with selected residues from the five conserved nucleotide 
binding motifs (G1–G5) shown in stick representation. Hydrogen bonds are indicated by dashed lines. 
An aspartate in the G4 motif is responsible for guanine specificity in dynamin superfamily members 
(19). In EHD4ΔN, the corresponding Asp225 does not participate in binding to the adenine base. The 
final 2Fo-Fc density was contoured at 1 σ around the nucleotides. (C) Superposition of the GTPase 
domains of AMPPNP-bound EHD2 and ATPγS-bound EHD4ΔN. In the EHD4 dimers (colored), the 
KPF loop (gold) folds back into a hydrophobic pocket of the GTPase domain. Inset shows the 
interaction of the R138 with the backbone of the switch I in EHD4, which is not present in EHD2 
(white). Note in particular that the highly conserved catalytic threonine residue (T97 in EHD4) points 
away from the nucleotide in EHD4ΔN. 
 
 
 
Figure S6. Reorientation of the linker in the active conformation. (A) The GTPase domains of EHD2 
and EHD4ΔN were superimposed. Highlighted is the position of Glu403 (represented as pink ball), the 
last resolved residue in the EHD4ΔN structure, corresponding to Glu400 in EHD2 (represented as 
purple ball). This residue is displaced by 12 Å through the rotation of the helical domain. (B) 
Autoinhibited EHD2 dimer (PDB ID code 4CID), in which the final helix α12 and the adjacent linker 
is shown in purple. (C) Detailed view showing the interaction of the helical domain-EH domain linker 
with the GTPase domain. The displacement of Glu400/Glu403 is indicated as in A. We suggest that 
the rotation pushes the linker away from its position in the autoinhibited state EHD2 dimer. In 
particular, Val409 and Phe412 will be shifted away from their hydrophobic binding pocket (marked as 
green circle). Consequently, also the GPF motif (residues 420–422, marked as orange circle), which 
binds to the opposing EH domain, may be displaced. 
 
Figure S7. Assembly of EHD4. (A) Crystal packing of ATPγS-bound EHD4ΔN, shown in two different 
views. The crystals are built of four EHD4 filaments, which are rotated 90° to each other (Left). 
In Right, alternate dimers are colored in blue and red (light/dark for the monomers). (B) Schematic 
arrangement of EHD4 dimers in the oligomer. At Right, the linear oligomer is shown from a side view. 
The distance between the first amino acid of EHD4ΔN (Gln22) and the membrane interacting Val359 
(corresponding to Cys356 in EHD2; Fig. 2) is 42 Å. To allow the N-terminal residues to insert into the 
same membrane leaflet as the primary membrane binding site in the helical domain, additional 
structural rearrangements, such as a partial unfolding of helix α1 may be required. Our previously 
published EPR data (16) showed that spin labels attached to the N terminus of EHD2 experience highly 
increased accessibility to oxygen in the presence of membranes, indicating that the N terminus is 
immersing into the membrane in the presence of liposomes (hence its denotation as “secondary 
membrane binding site”). Furthermore, continuous wave measurements revealed that N-terminal 
residues display increased mobility upon membrane binding, consistent with a release of the N 
terminus in the presence of membranes. In general, the N-terminal residues in EHD proteins are 
hydrophobic and highly conserved in the EHD family, suggesting a conserved function. However, in 
a cellular context (e.g., at caveolar or endosomal membranes), the exact position of the N terminus 
relative to the primary membrane binding site in the helical domain is not known. (C) Surface 
conservation plot of EHD4, using 39 EHD sequences from 20 different species. Conserved residues 
are shown in purple and nonconserved residues in cyan. Note that the oligomerization interface 
between the GTPase domain and helical domain is highly conserved. 
 
Figure S8. Activation mechanism of other membrane-associated proteins. (A) Crystal structure of the 
autoinhibited dynamin-3 tetramer (PDB ID code 5A3F). Based on a low-resolution EM reconstruction 
of oligomerized dynamin, it was suggested that the PH domains are released from the autoinhibitory 
stalk interface during activation and bind to the membrane, whereas the GTPase domains dimerize via 
the G-interface across helical turns (suggested movements are indicated by arrows). The PH domain 
release is thought to expose oligomerization interfaces in the stalk, therefore permitting 
oligomerization. Because there is no high-resolution structure of dynamin in the oligomerized state 
available, the exact mechanistic details of activation are still elusive. (B) The SNARE subunit 
Syntaxin-1A forms a closed autoinhibited four helix-bundle conformation (PDB ID code 3C98) and 
an open three helix-bundle conformation (comprising the “Habc domain,” PDB ID code 1S94). In the 
open state, the released H3 helix (magenta) associates with other SNARE partners to form the 
assembled SNARE complex. Binding of the regulatory Munc18a/Sec1-subunit stabilizes the 
autoinhibited conformation of syntaxin1A. (C) The ESCRTIII-component CHMP1B in the closed 
(modeled based on PDB ID code 3GGY) and open state (based on an electron microscopy 
reconstruction of the IST1-CHMP1B ESCRT-III copolymer, PDB ID code 3JC1). Domain opening 
exposes oligomerization interfaces in CHMP1B and allows assembly of a heteromeric scaffold. (D) 
Autoinhibited (PDB ID code 1EJ5) and active conformation (PDB ID code 1CEE) of the WASP 
protein. In the autoinhibited state, the CRIB domain tightly interacts with the VCA peptide. The small 
GTPase Cdc42 binds to the CRIB domain, therefore releasing the VCA peptide to induce actin 
polymerization. Domain opening is further promoted by PIP2 binding. (E) Crystal structure of the 
autoinhibited Syndapin/PACSIN-1 dimer comprising BAR and SH3 domains (PDB ID code 2X3W). 
Only one SH3 domain was observed in the crystal structure; the localization of the second SH3 
domains was modeled. Upon binding to proline-rich sequences of target proteins such as dynamin, the 
SH3 domains are released, therefore exposing the membrane binding site in the BAR domain to allow 
formation of a membrane-associated BAR domain scaffold. Similar to EHDs, these peripheral 
membrane proteins show a closed, autoinhibited conformation and an active open conformation. In the 
open conformation, self-assembly (dynamin, ESCRT-III), membrane binding (dynamin, PACSIN-1, 
ESCRT-III, WASP) or protein–protein interaction motifs (all examples) become exposed. However, 
the complex coupling of membrane binding to domain releases, rotations, and loop switches is specific 
for EHDs and possibly other dynamin proteins. 
  
Table S1: Data collection and refinement statistics  
 
 EHD4ΔN ATPγS EHD4ΔN ADP 
Data collection   
Space group P42212 P42212 
Cell dimensions   
    a, b, c (Å) 199.97, 199.97, 41.54 199.47 199.47,41.8  
 ()  90, 90, 90 90, 90, 90 
Resolution (Å) 48.5-2.79 (2.96-2.79)* 47.02 -3.27 (3.4-3.27) 
Rmerge (%) 9.5 (91.9) 28.8 (211.5) 
I / I 20.0 (1.9) 9.53 (1.02) 
Completeness (%) 99.8 (98.6) 99.54 (96.51) 
Redundancy 7.2  10.5 
   
Refinement   
Resolution (Å) 48.5-2.79 (2.89-2.79) 48.4 -3.27 (3.4-3.27) 
No. reflections 21,733 (2,091) 13642 (1273) 
Rwork / Rfree (%) 22.7/24.3 (32.8/34.2) 20.8/25.0 (35.8/39.1) 
No. atoms   
    Protein 3,072 3,026 
    Ligand/ion 32 28 
    Water 21 1 
B-factors (Å2)   
    Protein 75.6 105.5 
    Ligand/ion 100.3 146.5 
    Water 49.6 86.9 
R.m.s. deviations   
    Bond lengths (Å) 0.002 0.003 
    Bond angles () 0.54 0.59 
*Values in parentheses are for highest-resolution shell. 
n.a. – not applicable 
 
Movie S1: Activation mechanism of EHDs. Morph movie between the auto-inhibited EHD2 
(pdb 4CID) and the active EHD4 conformation indicates the molecular transitions during 
activation. Domain colors are as in Fig. 1E. Note that the EH-domains are not included in the 
movie. 
 
Movie S2: Proposed nucleotide-dependent assembly mechanism of EHDs into a curved 
membrane-associated scaffold.  
The proposed transition from the linear EHD4 scaffolds observed in the crystal lattice to ring-like 
scaffolds featuring the nucleotide-dependent G interface is illustrated from two perspectives. We 
suggest that formation of the G-interface involves a tilt of adjacent EHD dimers towards each other 
therefore coupling oligomerization with the creation of membrane curvature. 
 
